Azzad Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,262
Closed -$307K 406
2022
Q1
$307K Buy
4,262
+371
+10% +$26.7K 0.04% 302
2021
Q4
$357K Sell
3,891
-5,084
-57% -$608K 0.05% 308
2021
Q3
$1.14M Buy
8,975
+162
+2% +$23.6K 0.17% 209
2021
Q2
$1.47M Buy
8,813
+933
+12% +$151K 0.22% 181
2021
Q1
$1.43M Buy
7,880
+1,607
+26% +$373K 0.24% 174
2020
Q4
$1.25M Buy
6,273
+2,796
+80% +$569K 0.23% 163
2020
Q3
$762K Buy
+3,477
New +$736K 0.16% 202

Other funds holding TDOC

Azzad Asset Management's TDOC Position: Q2 2022 in Review

Azzad Asset Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,262 shares — an estimated $307K sold.

Azzad Asset Management first reported a position in TDOC in Q3 2020 and held it in 7 quarters. The position peaked at $1.47M in Q2 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Azzad Asset Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Azzad Asset Management sold 4,262 Teladoc Health shares in Q2 2022, an estimated $307K.
  • Azzad Asset Management first reported a position in Teladoc Health in Q3 2020 and held it in 7 quarters.
  • Azzad Asset Management's Teladoc Health position peaked at $1.47M in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Azzad Asset Management's 13F filing for Q2 2022, filed 1 Apr 2024.